FDA / regulator approved
Semaglutide
Ozempic®, Wegovy®, Rybelsus®
Catatan statusFDA-approved active ingredient in products including Ozempic, Rybelsus and Wegovy. Approval applies only to the registered product and formulation.
Regulatory map
Status regulator mengikut bahan
Semak perbezaan antara indikasi diluluskan, kelulusan negara lain, bahan kajian dan campuran bukan peptide. Status produk boleh berubah mengikut formulasi dan negara.
FDA / regulator approved
Tirzepatide
Mounjaro®, Zepbound®
Catatan statusFDA-approved in Mounjaro and Zepbound for different indications. Approval applies only to those registered products.
Kajian / tidak diluluskan
Retatrutide
None approved — development code LY3437943
Catatan statusFDA states retatrutide is not an ingredient in an approved drug and is not permitted for federal compounding.
FDA / regulator approved
Somatropin (HGH 191AA)
Genotropin®, Norditropin®, Humatrope®, Omnitrope®, Saizen®
Catatan statusMultiple FDA-approved somatropin products exist; approval is product- and indication-specific.
Kajian / tidak diluluskan
SLU-PP-322
None approved — research code only
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
Kajian / tidak diluluskan
Pinealon
Pinealon® (marketed name; verify local registration)
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
Kajian / tidak diluluskan
LL-37
None approved — research name only
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
FDA / regulator approved
PT-141 (Bremelanotide)
Vyleesi®
Catatan statusFDA approval applies to the Vyleesi 1.75 mg autoinjector, not generic PT-141 vials.
Kelulusan negara lain
Selank
Selank® (reported in Russia; not FDA-approved)
Catatan statusNot FDA-approved. Registration is reported in Russia and should be verified with the local regulator.
FDA / regulator approved
Oxytocin acetate
Pitocin®, Syntocinon®
Catatan statusFDA-approved oxytocin products exist and require clinical monitoring.
Kajian / tidak diluluskan
Epithalon
None approved — also marketed as Epitalon
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
Kajian / tidak diluluskan
BPC-157
None approved — BPC-157 is the research name
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
Kajian / tidak diluluskan
BPC-157 + TB-500
None approved — informal blend name only
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
FDA / regulator approved
SS-31 (Elamipretide)
Forzinity™ / elamipretide (country and indication status must be verified)
Catatan statusFDA granted accelerated approval to Forzinity (elamipretide) on 19 September 2025. Generic or unregistered SS-31 vials are not Forzinity.
Kajian / tidak diluluskan
CJC-1295 tanpa DAC
None approved — Mod GRF (1-29) is a research/marketed alias
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
Kajian / tidak diluluskan
CJC-1295 tanpa DAC + Ipamorelin
None approved — informal combination name only
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
Kajian / tidak diluluskan
CJC-1295 dengan DAC
None approved — CJC-1295 is the research name
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
Kajian / tidak diluluskan
DSIP
None approved — research name only
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
Bukan peptide / campuran
Melatonin
Circadin®, Slenyto®; many supplement brands
Catatan statusNot a peptide. Usually a supplement in the US and a regulated medicine in some other countries.
FDA / regulator approved
MT-1 (Melanotan I)
Scenesse® is approved afamelanotide; not equivalent to generic MT-1 vials
Catatan statusFDA/EMA approval applies to the Scenesse afamelanotide implant, not generic MT-1 vials.
Kajian / tidak diluluskan
MT-2 (Melanotan II)
None approved — Melanotan II is the marketed research name
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
Kelulusan negara lain
Semax
Semax® (reported in Russia; not FDA-approved)
Catatan statusNot FDA-approved. Registration is reported in Russia; verify the exact formulation and indication locally.
Kajian / tidak diluluskan
Semax + Selank
None approved — informal combination only
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
Kajian / tidak diluluskan
TB-500 (Thymosin beta-4 fragment)
None approved — TB-500 is the marketed research name
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
FDA / regulator approved
hCG
Pregnyl®, Novarel®, Ovidrel® (choriogonadotropin alfa)
Catatan statusFDA-approved hCG products exist; approval is limited to licensed products and label indications.
Kajian / tidak diluluskan
AOD-9604
None approved — AOD-9604 is the development name
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
Kajian / tidak diluluskan
IGF-1 LR3
None approved — research name; not Increlex® (mecasermin)
Catatan statusIGF-1 LR3 is not FDA-approved and is not the same as licensed mecasermin.
FDA / regulator approved
Tesamorelin
Egrifta SV®, Egrifta WR®
Catatan statusFDA approval applies to Egrifta products and their labelled formulation; generic or unregistered vials are not equivalent.
Kajian / tidak diluluskan
Ipamorelin
None approved — research name only
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
Kajian / tidak diluluskan
AHK-Cu
No approved drug brand; cosmetic ingredient name AHK-Cu
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
Kajian / tidak diluluskan
GHK-Cu
No approved injectable brand; cosmetic ingredient name Copper Tripeptide-1
Catatan statusNo FDA-approved injectable drug. Cosmetic use does not establish injection safety.
Kajian / tidak diluluskan
Kisspeptin-10
None approved — research name only
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
Kelulusan negara lain
Thymosin alpha-1 (Thymalfasin)
Zadaxin® (registered in some countries)
Catatan statusNot FDA-approved. Thymalfasin is registered in some countries; local label and indication must be verified.
Kajian / tidak diluluskan
MOTS-c
None approved — research name only
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
Kelulusan negara lain
Sermorelin acetate
Geref® (historical/discontinued US product)
Catatan statusThe former US product was discontinued; current generic vials are not FDA-approved products.
Bukan peptide / campuran
Glutathione
Generic glutathione products; no FDA-approved skin-lightening injection brand
Catatan statusNot a peptide. No FDA approval for skin-lightening injections.
FDA / regulator approved
Botulinum toxin
Botox®, Dysport®, Xeomin®, Jeuveau®, Daxxify®, Letybo®
Catatan statusSeveral FDA-approved formulations exist; units are not interchangeable between products.
Bukan peptide / campuran
5-Amino-1MQ
None approved — research compound name only
Catatan statusThis is not an approved peptide medicine under the quoted formulation. Product and country registration must be checked separately.
Kelulusan negara lain
Cerebrolysin
Cerebrolysin® (registered in some countries)
Catatan statusNot FDA-approved. Registration exists in some countries and must be verified locally.
Kajian / tidak diluluskan
Cagrilintide
None approved — development name AM833
Catatan statusFDA states cagrilintide is not an ingredient in an approved drug and is not permitted for federal compounding.
Kajian / tidak diluluskan
ARA-290 (Cibinetide)
None approved — cibinetide is the development name
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
Bukan peptide / campuran
SNAP-8
Argireline® Amplified peptide / Acetyl Octapeptide-3 cosmetic ingredient
Catatan statusCosmetics are not FDA-approved drugs; an injectable vial has no approved indication.
Bukan peptide / campuran
NAD+
Generic NAD+ wellness products; no approved anti-ageing brand
Catatan statusThis is not an approved peptide medicine under the quoted formulation. Product and country registration must be checked separately.
Kajian / tidak diluluskan
BPC-157 + GHK-Cu + TB-500
None approved — informal blend name only
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
Kajian / tidak diluluskan
VIP
None approved as generic VIP — research name only
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
Kajian / tidak diluluskan
KPV
None approved — research name only
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
Kajian / tidak diluluskan
BPC-157 + GHK-Cu + TB-500 + KPV
None approved — informal blend name only
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
Kajian / tidak diluluskan
GHRP-2
None approved — pralmorelin is a related development name
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
Kajian / tidak diluluskan
GHRP-6
None approved — research name only
Catatan statusNo FDA-approved medicine was identified for this substance or combination. A research or marketed name is not a regulatory approval.
FDA / regulator approved
Vitamin B12
Nascobal®; generic cyanocobalamin/hydroxocobalamin products
Catatan statusNot a peptide. Licensed cyanocobalamin and hydroxocobalamin medicines exist.
Bukan peptide / campuran
AICAR
None approved — acadesine/AICAR development names
Catatan statusThis is not an approved peptide medicine under the quoted formulation. Product and country registration must be checked separately.
Bukan peptide / campuran
Bacteriostatic water
Bacteriostatic Water for Injection, USP (multiple manufacturers)
Catatan statusNot a peptide or active medicine. Use a registered product and only the diluent named by the medicine label.
Bukan peptide / campuran
Lipo-C / MIC blends
Lipo-C / MIC — compounding or marketed formula names
Catatan statusThis is not an approved peptide medicine under the quoted formulation. Product and country registration must be checked separately.
Bukan peptide / campuran
Lemon Bottle
Lemon Bottle® (marketing name; verify local registration)
Catatan statusNot a peptide and not an FDA-approved fat-dissolving injection under this name. Verify local registration.
FDA / regulator approved
L-Carnitine formulations
Carnitor®; generic levocarnitine products
Catatan statusNot a peptide. Licensed levocarnitine products exist for specific indications; generic or unregistered vials do not inherit those approvals.
Bukan peptide / campuran
Lipo-C Fat Blaster
Lipo-C Fat Blaster — marketed formula name
Catatan statusThis is not an approved peptide medicine under the quoted formulation. Product and country registration must be checked separately.
Bukan peptide / campuran
Super Shred
Super Shred — marketed formula name
Catatan statusThis blend is not FDA-approved; albuterol approval applies only to specific licensed products and indications.
Bukan peptide / campuran
Super Human Blend
Super Human Blend — marketed formula name
Catatan statusThis is not an approved peptide medicine under the quoted formulation. Product and country registration must be checked separately.
Bukan peptide / campuran
Healthy Hair Skin Nails Blend
Healthy Hair Skin Nails Blend — marketed formula name
Catatan statusThis is not an approved peptide medicine under the quoted formulation. Product and country registration must be checked separately.